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Abstract
Mast cells are key participants in allergic diseases via activation of high-affinity IgE receptors (FcϵRI)
resulting in release of proinflammatory mediators. The biochemical pathways linking IgE activation to
calcium influx and cytoskeletal changes required for intracellular granule release are incompletely
understood. We demonstrate, genetically, that Pak1 is required for this process. In a passive cutaneous
anaphylaxis experiment, W /W  mast cell–deficient mice locally reconstituted with Pak1  bone
marrow–derived mast cells (BMMCs) experienced strikingly decreased allergen-induced vascular
permeability compared with controls. Consistent with the in vivo phenotype, Pak1  BMMCs exhibited
a reduction in FcϵRI-induced degranulation. Further, Pak1  BMMCs demonstrated diminished
calcium mobilization and altered depolymerization of cortical filamentous actin (F-actin) in response to
FcϵRI stimulation. These data implicate Pak1 as an essential molecular target for modulating acute
mast cell responses that contribute to allergic diseases.
Introduction
Mast cells are found in tissues where there is frequent contact between the host and the environment.
These cells function as key sensors of foreign antigens and initiate inflammatory processes including
anaphylaxis, allergy, and asthma.  Antigenic challenge activates FcϵRI, the high-affinity IgE receptor,
which triggers the immediate release of preformed mediators from cytoplasmic granules
(degranulation) via secretory granule translocation followed by vesicle and plasma membrane fusion.
Delayed responses to FcϵRI activation also include production and secretion of eicosanoids and
inflammatory cytokines. Thus, mast cells play a central role in the initiation and propagation of a local
inflammatory response, resulting in many of the symptoms of acute and chronic allergic diseases.
The tetrameric FcϵRI receptor binds IgE and transduces signals via a large macromolecular signaling
complex at the plasma membrane. Subsequent activation of multiple kinases and phosphatases, as well
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as calcium and lipid signals must be coordinated to impact cytoskeletal changes resulting in mast cell
degranulation. The importance of changes in intracellular calcium concentration in degranulation is
well established.  Allergen-induced mast cell degranulation involves a calcium-dependent process
triggered by depletion of calcium from intracellular stores followed by calcium entry from the
extracellular environment via store-operated calcium channels.  The resultant sustained increase in
cytoplasmic calcium facilitates granule movement, membrane fusion, and exocytosis via actin filament
and microtubule reorganization.  Speaking to the complexity of this molecular machinery, there is
also evidence to suggest that cytoskeletal elements themselves participate in the regulation of calcium
entry.  Despite significant investigation and progress in understanding this complex process, much
remains unknown about the downstream effectors that link early FcϵRI targets to cellular changes that
promote degranulation.
Studies using pharmacological inhibitors and genetic models have established that, by interacting with
multiple target proteins, PI3-K and small RhoGTPases regulate calcium mobilization and cytoskeletal
changes that are integral to FcϵRI-mediated mast cell degranulation.  One shared class of
mediators that independently receives signals from PI3-K and RhoGTPases is the family of p21-
activated kinases (Paks) (reviewed in Kumar et al  and Hofmann et al ). Pak1 is a Pak family
member whose expression is restricted principally to brain, muscle, and hematopoietic cells (reviewed in
Bokoch  and Sells et al ). In nonhematopoietic cells, Paks induce the temporal and spatial formation
of cortical actin structures similar to those regulated by Rac and Cdc42, including membrane ruffles,
lamellipodia, filopodia, and focal complexes.  Given that degranulation involves complex
cytoskeletal rearrangements and that Paks regulate filamentous actin (F-actin) dynamics, we
investigated a potential role for Pak1 in allergen-stimulated mast cell de granulation.
Here we generated a Pak1  mouse to elucidate the role of Pak1 in allergen-induced mast cell
function. We provide in vivo and in vitro evidence that Pak1 is necessary for appropriate mast cell
degranulation, although loss of Pak1 does not impact the life span, growth, or fertility of the Pak1
mouse. We report a biochemical mechanism by which Pak1 impacts degranulation by regulation of F-
actin, calcium signaling, and vesicle translocation. Our findings suggest that, although F-actin
polymerization in response to IgE sensitization is independent of Pak1 function, Pak1 is critical for
disassembly of cortical F-actin upon allergen stimulation, a process that provides mast cell granules
access to the plasma membrane.  These studies establish a vital role for Pak1 in regulating mast cell
function and warrant further examination of Pak1 as a potential therapeutic target in allergen-mediated
inflammatory processes.
Methods
Mice
Pak1  mice were backcrossed 10 generations onto a C57Bl/6J strain. Syngeneic WT and Pak1
mice progeny from this backcross were used for experimentation. Animal care and experimental
procedures were conducted on a protocol approved by the Fox Chase Cancer Center Institutional
Animal Care and Use Committee and the Indiana University Laboratory Animal Research Center.
Southern blot
Genomic DNA was isolated for Southern blot using a standard phenol chloroform extraction, followed
by digestion with HindIII, separation of the DNA fragments via gel electrophoresis, transfer of the gel to
a nitrocellulose membrane, and hybridization with a P-labeled 1-KB Xba1-BamHI genomic probe.
Genotyping by PCR
Purified (Puregene; Gentra, Minneapolis, MN) tail DNA was used for polymerase chain reaction (PCR)
designed to amplify DNA fragments from the WT and targeted Pak1 alleles simultaneously. A common
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forward primer (5′-GCC CTT CAC AGG AGC TTA ATG A-3′) was used with a pak1-specific reverse
primer (5′-GAA AGG ACT GAA TCT AAT AGC A-3′) to amplify a 240-bp product from the WT allele;
and with a neo-specific reverse primer (5′-CAT TTG TCA CGT CCT GCA CGA-3′) to amplify a 360-bp
product from the targeted allele.
Western blotting
Whole-cell lysates were prepared by addition of 1 × SDS sample buffer to 10  bone marrow–derived
mast cells (BMMCs). Cells were sonicated, clarified by centrifugation, and quantified using a BCA
reagent assay (Thermo Scientific, Waltham, MA). Samples were separated by SDS–polyacrylamide gel
electrophoresis (PAGE) on a 4% to 12% gradient gel (Invitrogen, Frederick, MD) and transferred to
PVDF membrane. Blots were probed with anti-Pak1 antibody (1:1000; Cell Signaling, Beverly, MA)
then visualized with HRP-conjugated goat anti–rabbit IgG antibody (1:5000; R&D Systems,
Minneapolis, MN). To prepare whole-cell lysates for the phospholipase Cγ1 blots, BMMCs (2 × 10 )
were stimulated (“Cell culture and activation”) and lysed with ProteoJET Mammalian Cell Lysis
Reagent (Fermentas, Hanover, MD), clarified, and quantified using BCS reagent assay (Thermo
Scientific). Proteins were separated on an 8% Tris-glycine polyacrylamide gel or 4% to 12% gradient Bis-
Tris polyacrylamide precast gel (Invitrogen), transferred to PVDF, and probed with anti–phospho-
phospholipase Cγ1 (1:1000; Cell Signaling) or anti–total phospholipase Cγ1 (1:1000; Cell Signaling). All
blots used an HRP-conjugated antirabbit secondary antibody (Amersham, Arlington Heights, IL), and
films were developed using the enhanced chemiluminescence (ECL) plus system (Amersham).
Phosphorylated proteins were quantified by subjecting autoradiographs to densitometry (NIH Image
software; National Institutes of Health [NIH], Bethesda, MD).
Reverse transcription–PCR
Total RNA was isolated with the RNeasy mini protocol kit (QIAGEN, Valencia, CA), using 2× excess
DNAse I treatment (RNnase-Free DNase set; QIAGEN). Superscript First-Strand Synthesis System
(Invitrogen) was used to synthesize cDNA from 5 μg RNA. cDNA was amplified with 2 mM MgCl ,
200 μM PCR nucleotide mix, 0.04 U Taq DNA polymerase, and 300 nM of the following primers: PAK1
sense, 5′-GGCAGCAAAGACACTGGAACCCTA-3′; PAK1 antisense, 5′-
CTCATGTACTTCTTACTATTGGAGGTC-3′; GAPDH sense, 5′-CTGGTGCTGAGTATGTCGTG-3′; and
GAPDH antisense, 5′-CAGTCTTCTGAGTGGCAGTG-3′. Amplification included initial denaturation at
95°C × 5 minutes, denaturation at 95°C × 1 minute, elongation at 58°C × 1 minute, and annealing at
72°C × 1 minute, for 34 cycles.
Cell culture and activation
BMMCs were selectively grown in IMDM medium supplemented with 10 U/mL penicillin, 0.1 mg/mL
streptomycin, 1% L-glutamine, 10% FBS, and 5 ng/mL mIL-3 (Peprotech, Rocky Hill, NJ) for 5 to 8
weeks. BMMCs were cultured for 5 to 8 weeks, sensitized in media with 1.5 μg/mL anti-DNP IgE
monoclonal antibody (clone SPE-7; Sigma-Aldrich, St Louis, MO) for 4 hours, and stimulated with 30
ng/mL dinitrophenyl conjugated to human serum albumin (DNP-HSA, 30-40 mol DNP/mol HSA;
Sigma-Aldrich). IPA-3 is an isoform-selective, small molecule inhibitor that targets the autoregulatory
mechanism of p21-activated kinases. For the IPA-3 treatment, cells were sensitized as described and
then pretreated for 10 minutes with 30 μM IPA-3 prior to the addition of the DNP stimulation.
Detection of c-kit/FcϵRI receptors
C-kit and FcϵRI expression were analyzed by fluorescence cytometry as described.  Cells were blocked
with unconjugated anti-FcγRII/III (BD Pharmingen, San Diego, CA) and stained with anti-DNP
monoclonal antibody IgE clone SPE-7 (Sigma-Aldrich), anti–mouse CD 117 (c-kit) PE-conjugated
antibody, and FITC-conjugated anti–mouse IgE (both BD Pharmingen) secondary antibody. Cells were
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washed and resuspended in 0.5% BSA PBS buffer. Aliquots of BMMCs were also stained with FITC- and
PE-conjugated rat IgG2b, K; isotype antibodies as negative controls. Cells were analyzed on a
fluorescence-activated cell sorting (FACS) Calibur (Becton Dickinson, San Jose, CA). Data were
analyzed by unpaired, 2-tailed Student t test.
Pak1 kinase assay
BMMCs were sensitized and stimulated (see “Cell culture and activation”) at 37°C for 1 minute and the
reaction was terminated by addition of 1 mM Na VO  in cold PBS. Whole-cell lysate (400 μg) was
prepared as previously described,  and a 10-μL aliquot of each sample was reserved for detection of β-
actin to serve as a loading control. The remainder of the lysate was immunoprecipitated with 2 μg/mL
α-Pak1 antibody (N20; Santa Cruz Biotechnology, Santa Cruz, CA) at 4°C for 18 hours before
incubation with protein A/G plus beads (Santa Cruz Biotechnology) for 2 hours. Pak activity was
assayed by incubating the immunobeads with 1 μg/reaction inactive Mek (Millipore, Billerica, MA) and
250 μM ATP (Sigma-Aldrich) in 30 μL kinase buffer.  Samples were separated by 10% SDS-PAGE,
transferred to nitrocellulose, and probed with anti–Mek-phospho-serine 298 (1:1000; Biosource,
Camarillo, CA). Phosphorylated Mek was quantified by subjecting autoradiographs to densitometry
(NIH Image software).
Degranulation
BMMC degranulation was determined by β-hexosaminidase release as previously described  with
minor modification. IgE-primed (see “Cell culture and activation”) BMMCs were suspended at 2 × 10
cells/mL in Tyrode buffer (10 mM HEPES buffer, 130 mM NaCl, 5 mM Kcl, 1.4 mM CaCl , 1 mM
MgCl , 5.6 mM glucose, 0.05% BSA, pH = 7.4) then stimulated with 30 ng/mL DNP-HSA (Sigma-
Aldrich) for 15 minutes at 37°C. For receptor-independent stimulation, unsensitized cells were incubated
in Tyrode buffer and stimulated with 1 μM calcimycin for 15 minutes. The cell pellets were solubilized in
Tyrode buffer, 0.5% Triton X-100. β-Hexosaminidase release was measured in both the supernatants
and the cell pellets by incubating with 4-nitrophenyl N-acetyl-beta-D-glucosaminide (Sigma-Aldrich) in
sodium citrate (pH 4.5) for one hour at 37°C. Sodium carbonate/sodium bicarbonate buffer (0.1 M, pH
10) was used to stop the reaction and absorbance was read at 405 λ. Degranulation was expressed as a
percentage of β-hexosaminidase released = supernatant activity/total (supernatant plus pellet) activity
×100. Samples were assayed in triplicate. Data were graphed using Prism (GraphPad Software, San
Diego, CA) and analyzed by unpaired, 2-tailed Student t test.
Calcium mobilization
IgE-primed BMMCs were suspended at 10  cells/mL in 0.1% BSA in RPMI 1640 containing 3 μM fura-
2-AM (Molecular Probes, Eugene, OR) at 37°C for 1 hour. Cells were washed and resuspended at 10
cells/mL in calcium-containing HBSS without phenol red. Samples were warmed to 37°C and
stimulated with either 1 μM calcimycin (A23187) or DNP-HSA (30 ng/mL). In some experiments,
extracellular calcium was removed prior to stimulation by the addition of 10 mM EGTA. Fura-2
fluorescence was monitored using an F-2000 spectrophotometer (Hitachi, Tokyo, Japan) as previously
described.  Measurements were performed at 37°C with constant stirring. The excitation and emission
wavelengths of fura-2 are 340λ and 380λ. Subsequent addition of 80 μg/mL digitonin then 10 mM
EGTA allowed determination of maximum and minimum fura-2 fluorescence for calculation of
[iCa]  and [iCa]  as described.  Data were graphed using Prism (GraphPad Software) and
analyzed by unpaired, 2-tailed Student t test.
Confocal microscopy
BMMCs were allowed to adhere to glass slides then fixed in 3.7% paraformaldehyde in phosphate-
buffered saline (PBS: 1.76 mM KH PO , 10.14 mM Na HPO , 2.68 mM KCl, and 136.8 mM NaCl) for
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15 minutes at room temperature. Cells were permeabilized with 0.1% Triton X-100 in PBS for 5
minutes, washed in PBS, then incubated with Alexa Fluor488 phalloidin (1 unit) or rhodamine-
phalloidin (Invitrogen) for 30 minutes. After washing in PBS, fluorescence analysis was performed
using the Zeiss LSM 510 confocal laser scanning system (Carl Zeiss, Heidelberg, Germany) using a
100× (oil) magnification. The intensity of F-actin staining was quantified using ImageJ software (NIH)
and data were analyzed by unpaired, 2-tailed Student t test.
Passive cutaneous anaphylaxis
Adoptive transfer studies were conducted as previously described  using mast cell–deficient Kit
W /W  mice purchased from Jackson Laboratories (Bar Harbor, ME). BMMCs (10 ) in 40 μL
IMDM were injected intradermally into each ear of 6- to 8-week-old female Kit W /W  mice. Twelve
weeks after intradermal injection, each mouse was primed to express an IgE-dependent passive
cutaneous anaphylaxis (PCA) reaction. Mice were anesthetized with avertin and received an
intradermal injection to the right ear of 20 μL of 1:44 dilution of monoclonal anti-DNP IgE in PBS
(clone SPE-7; Sigma-Aldrich). The left ear received an intradermal injection of 20 μL PBS alone.
Twenty hours after injection, the mice received 300 μL of a 10-mg/mL DNP-human serum albumin
(HSA) (Sigma-Aldrich) and 1% Evans blue (Sigma-Aldrich) solution intravenously. Thirty minutes
later, the mice were killed, imaged using an Epson perfection 4990 photo scanner. Tissue samples were
acquired by 5-mm punch biopsy at the sensitization site. Dye was extracted with 1N KOH overnight at
37°C. The next day 900 μL extraction buffer (85% H PO , acetone, and H O) was added to digested ear
and followed by sample agitation and centrifugation. Samples were read at 620 nm with a
spectrophotometer. Data were analyzed by unpaired, 2-tailed Student t test.
Generation of recombinant Pak1 construct and supernatants
The BsmB1-adapted pEGFP-PAK1 cDNA was ligated into the Age1/BsmB1 site of the pCL1 lentiviral
backbone provided by Dr Helmut Hanenberg. LV-containing supernatant was generated via
transfection of 293T cells with a recombinant foamy virus envelope plasmid and the LV helper plasmid
pCD/NL-BH using 45 μg polyethylenimine (PEI; Sigma-Aldrich). Packaging cells were maintained in
high glucose Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum, 10 U/mL
penicillin, and 0.1 mg/mL streptomycin, 1% L-glutamine, and 2% NaHCO  as previously described.
Generation of recombinant CD63-EGFP supernatants
The pMX-CD63-EGFP retroviral plasmid was kindly provided by Dr Keigo Nishida at Riken Research
Center for Allergy and Immunology (Kanagawa, Japan). RV-containing supernatant was generated via
transfection in an ecotropic packaging cell line using a calcium phosphate transfection kit (Invitrogen)
to generate recombinant retrovirus.
Transduction of mast cell progenitors
Transduction of mast cells was accomplished using previously published methods from our
laboratory.  Mice were injected with 5-fluorouracil (150 mg/kg; American Pharmaceutical Partners,
Schaumburg, IL). Bone marrow cells were harvested 48 hours after injection. Mononuclear cells
obtained after density gradient centrifugation were cultured for 2 days in the presence of stem cell factor
100 ng/mL, G-GSF 100 ng/mL, and IL-6 200 U/mL (all from Peprotech). The cells were infected with
either pCL1EGFP or pCL1EGFPPAK 1 virus supernatant on FN CH-296–coated plates overnight. On
day 3 after infection, the green fluorescent protein–positive cells were isolated by fluorescence-activated
cell sorter (FACStar Plus; Becton Dickinson) under sterile conditions and expanded in BMMC conditions
for 6 to 8 weeks.
Results
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Genetic disruption of murine Pak1
A Pak1  mouse was generated by targeted disruption of the Pak1 allele in embryonic stem (ES) cells.
The resultant allele contains a neomycin cassette and is lacking 2 kb genomic DNA encoding the p21-
binding domain (Figure 1A). Southern blot analysis of tail DNA from Pak1 , Pak1 , and Pak1
reveals the presence of the expected genotypes (Figure 1B). Pak1  mice are observed at the predicted
Mendelian frequency and are viable and fertile. Pak1  mice have a normal life span and normal
peripheral blood cell indices (Table 1). To verify that Pak1  mice produce no Pak1 protein, cell lysates
isolated from WT and Pak1  BMMCs were subjected to Western blot using a Pak1-specific antibody (
Figure 1B). Western blots of whole brain lysates and murine embryonic fibroblasts were also performed
(data not shown). No Pak1 protein was observed in any cells from the Pak1  mice. To further
document the absence of Pak1 protein being expressed at levels below detection of Western blot, reverse-
transcription (RT)–PCR was conducted to look for expression of the Pak1 mRNA transcript. As
expected, Pak1 mRNA was detected in WT BMMCs, but no Pak1 mRNA was detected in Pak1
BMMCs (Figure 1B).
Mast cell development is not affected by genetic disruption of Pak1
Mast cells were cultured from murine bone marrow in the presence of serum and interleukin 3 (IL-3),
and expression of cell surface receptors typical of mature mast cells, including c-kit receptor and FcϵRI
receptor, was examined. Fluorescence cytometric analysis of WT and Pak1  mast cells demonstrated
equivalent expression of both c-kit and FcϵRI receptors (mean 96.1 ± 2.3 SEM % vs 95.3 ± 1.7 SEM %
double-positive cells, respectively; n = 6). A representative mast cell population of each genotype is
shown in Figure 2A. Further, Pak1  cells had typical cellular morphology and staining of cytoplasmic
granules upon Alcian blue/saffranin-O staining (data not shown). The frequency of mast cells in the
peritoneum and in the dermis of the ear is equivalent in WT and Pak1  mice (Table 1). These results
indicate that genetic disruption of Pak1 did not influence mast cell differentiation in vitro or in vivo.
Pak1 is activated upon antigen cross-linking of FcϵRI
We sought to determine the role of Pak1 in signal transduction pathways activated by FcϵRI cross-
linking. Lysates from IgE-stimulated mast cells of both genotypes were subjected to an in vitro kinase
assay to determine whether Pak1 is normally activated as a consequence of IgE stimulation.
Recombinant Mek1 protein was used as a phosphorylation substrate following immunoprecipitation of
Pak1, since Pak1 and Pak2 have been established to specifically phosphorylate Mek1 at serine 298 (Mek1
S298).  There is minimal background phosphorylation of the Mek1 substrate at baseline and upon
stimulation of Pak1  BMMCs. In contrast, a 2.5-fold increase in Mek1 S298 phosphorylation was
observed in WT mast cells (Figure 2B), demonstrating that FcϵRI cross-linking results in Pak1
activation. In an independent experiment, Mek1 S298 phosphorylation was measured by Western blot
at baseline and following FcϵRI activation. Consistent with the kinase assay, a significant reduction in
Mek 1 S298 phosphorylation was observed in Pak1  cells at both 1 and 5 minutes following activation
(Figure 2C). Finally, in a replicate experiment, cells were incubated with an established inhibitor of Pak1
and Pak2 prior to FcϵRI cross-linking. Complete inhibition of Mek1 S298 phosphorylation was observed
at multiple time points (Figure 2D). Collectively these genetic, biochemical, and pharmacologic data
indicate that Pak1 is activated following FcϵRI activation.
Pak1 is required for normal mast cell function in vitro
To determine the impact of loss of Pak1 on mast cell degranulation, we compared FcϵRI-mediated
degranulation in WT and Pak1  mast cells. Purified populations of IgE-sensitized WT and Pak1
BMMCs were stimulated with antigen to achieve FcϵRI cross-linking. The concentration of β-
hexosaminidase, an enzyme present in preformed mast cell granules, was measured in the supernatant
and in the cell pellet. Total β-hexosaminidase content in BMMCs of the 2 genotypes was equivalent,
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indicating that Pak1 is not required for synthesis of this enzyme (data not shown). However, Pak1
BMMCs had a 3-fold reduction in release of β-hexosaminidase upon FcϵRI stimulation (10.7% ± 1.1%)
compared with cells from syngeneic, WT age- and sex-matched controls (32.1% ± 4.2%) (n = 4, 
Figure 3A). Stimulation of mast cells in a non–receptor-dependent fashion by calcimycin (A23187)
resulted in comparable levels of degranulation between the 2 genotypes (Figure 3A). These data
implicate a specific role for Pak1 in mediating FcϵRI-stimulated degranulation.
CD63 is located on granule and plasma membranes in resting basophils and mast cells. We transduced
WT and Pak1  mast cells with a retrovirus encoding a CD63-EGFP fusion protein to visualize
degranulation.  Cells were also stained with DAPI to allow nuclear detection. Following FACS
sorting of the transduced cells, BMMCs of both genotypes were imaged at baseline, after IgE
sensitization, and after FcϵRI cross-linking. Significantly more cells containing CD63-EGFP–positive
vesicles remained after stimulation in the Pak1  BMMCs compared with WT mast cells (Figure 3B)
consistent with the genotypic differences in β-hexosaminidase release.
To verify that the defect in degranulation is due to disruption of the Pak1 gene, as a proof of principle,
we transduced Pak1  hematopoietic progenitors with a lentivirus encoding an EGFP-Pak1 fusion
protein (or “vector alone,” encoding EGFP only in the case of controls), sorted for transduced cells, and
differentiated these cells into BMMCs under standard culture conditions. The recombinant Pak1
transgene is expressed at levels that are close to that of endogenous Pak1 (Figure 3C). Pak1  BMMCs
transduced with vector alone showed decreased degranulation compared with WT controls (Figure 3D),
consistent with previous experiments. Importantly, Pak1  BMMCs reconstituted with WT Pak1, were
able to degranulate in response to FcϵRI cross-linking to the same degree as WT control BMMCs. This
finding underscores the importance and specificity of Pak1 in allergen-induced mast cell degranulation
in vitro.
FcϵRI-dependent calcium mobilization is altered in Pak1  BMMCs
Stimulation of mast cells by calcimycin in a non–receptor-dependent fashion caused equivalent
increases in intracellular calcium concentration ([Ca ]; data not shown) and comparable levels of
degranulation between the 2 genotypes (Figure 3A). This observation together with the profound
decrease in degranulation of Pak1  BMMCs following FcϵRI-dependent degranulation led us to
question the involvement of Pak1 in allergen-induced calcium mobilization. IgE-sensitized BMMCs of
both genotypes were loaded with fura-2, suspended in calcium-containing HBSS, and stimulated with
DNP-HSA. Spectrophotofluorimetric analysis measuring calcium-bound versus unbound fura-2
fluorescence was used to measure baseline and stimulated intracellular calcium concentration. Baseline
levels of intracellular [Ca ] were similar in WT and Pak1  BMMCs and, in both genotypes,
maximum emission from calcium-bound fura-2 occurred within seconds of stimulus addition.
Compared with controls, the change in intracellular [Ca ] was significantly diminished in Pak1
BMMCs after antigen stimulation (Figure 4A).
Since calcium release from intracellular stores is a discrete event preceding calcium influx from the
extracellular environment, we differentiated the 2 processes by also performing experiments in the
absence of extracellular calcium. In calcium-free media plus EGTA, the peak increase in calcium
concentration after antigen stimulation is similar between the 2 genotypes (Figure 4B), indicating
normal calcium release from intracellular stores. Consistent with this data, allergen-stimulated PLCγ1
activation, which leads to IP3-dependent release of calcium from the endoplasmic reticulum, is similar
in WT and Pak1  mast cells (Figure 4C). We also confirmed equivalent Rac activation after FcϵRI
cross-linking in WT and Pak1  BMMCs (data not shown). Thus, the role of Pak1 in regulating
calcium mobilization appears to be distinct from that of Rac proteins, which exert their effect on
calcium mobilization through regulation of PLCγ1/2 and altered release from intracellular stores.
Our results suggest that, in BMMCs, Pak1 is involved in receptor-mediated calcium influx from the
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extracellular environment.
Pak1  BMMCs have altered actin cytoskeletal dynamics
An increase in intracellular calcium is essential for FcϵRI-mediated F-actin ring disassembly and
degranulation.  Given our finding of an attenuated increase in intracellular calcium in Pak1
BMMCs, as well as published observations that overexpression of a kinase dead K299R Pak1 mutant
stabilizes F-actin in breast cancer cells,  we hypothesized that Pak1 may affect degranulation through
alteration of actin cytoskeletal dynamics. To test this hypothesis, we used confocal microscopy to
visualize changes in cortical F-actin in WT and Pak1  BMMCs. IgE sensitization of a WT mast cell
leads to enhancement of the cortical F-actin ring and subsequent FcϵRI cross-linking induces
disassembly of this structure in a majority of cells (Figure 5A). Sensitization of Pak1  BMMCs also
induces organization of cortical F-actin that appears exaggerated in some cells. Importantly, in Pak1
BMMCs, cortical F-actin persists after allergen stimulation (Figure 5A). In 4 experiments conducted
from independent primary mast cell lines, the percentage of cells displaying fragmentation of the
cortical F-actin ring upon FcϵRI stimulation was significantly greater in the WT BMMCs (87.5% ±
3.6%) compared with the Pak1  BMMCs (29.0% ± 5.3%; n = 400 cells, Figure 5B). A similar
reduction in total F-actin was observed using fluorescence cytometry. Thirty seconds after cross-linking
of the FcϵRI receptor, there is a 35% reduction in F-actin compared with only a 5% to 7% reduction in
F-actin in Pak1  mast cells. The genotypic differences in F-actin are maintained in serial
measurements over 5 minutes (data not shown). Addition of latrunculin, a compound that promotes F-
actin depolymerization, enhanced F-actin depolymerization in both WT and Pak1  BMMCs (Figure
S1, available on the Blood website; see the Supplemental Materials link at the top of the online article).
Analogous to the correction of FcϵRI-stimulated β-hexosaminidase release in Pak1  BMMCs by
lentiviral reintroduction of WT Pak1 (Figure 3B), expression of the Pak1 transgene in Pak1  BMMCs
restored F-actin disassembly to WT levels, whereas gene transfer with only a reporter gene did not (
Figure 5C). Overall, this microscopy data argue for a central role for Pak1 in mediating F-actin
disassembly.
Pak1 is required for normal mast cell degranulation in vivo
Passive cutaneous anaphylaxis (PCA) is a profound localized allergic reaction triggered by allergen-
induced cross-linking of FcϵRI by the binding of an allergen-specific IgE placed beneath the skin. We
used a PCA model to examine whether Pak1 is important in mast cell degranulation in vivo. The ears of
WT and Pak1  mice were first sensitized by intradermal injection of monoclonal anti-DNP IgE.
Twenty hours after cutaneous sensitization, IgE cross-linking was induced by systemic injection of the
antigen, DNP-HSA, with Evans blue dye. The Evans blue dye extravasation was quantified 20 minutes
after antigen challenge. This extravasation process is reflective of increased local vascular permeability,
a process dependent on mast cell release of histamine and serotonin upon degranulation. The amount of
dye in the ear was both qualitatively (Figure 6A) and quantitatively (Figure 6B) reduced in the Pak1
mice, indicating an important role for Pak1 in the mast cell–mediated immediate-phase PCA reaction.
To validate that the genotypic reduction in extravasation is indicative of a cell-autonomous genotypic
effect on mast cells, WT or Pak1  mast cell progenitors were transplanted into the subcutaneous
tissue of the ears of mast cell–deficient (W /W ) mice as previously described.  The cells were
allowed to differentiate in this microenvironment for 12 weeks. Thus, in this model, only the mast cells
varied in genotype (WT or Pak1 ) with all other cell lineages (other inflammatory cells, endothelial
cells, fibroblasts, etc) expressing endogenous Pak1. Mice that underwent transplantation were sensitized
by intradermal injection of monoclonal anti-DNP IgE in one ear (and PBS in the other as a control),
followed by systemic injection of the antigen, DNP-HSA, with Evans blue dye the following day as in
previous studies, and Evans blue dye extravasation was quantified after antigen challenge as in previous
studies. The amount of dye in the ear was dramatically reduced in the mice locally reconstituted with
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Pak1  BMMCs compared with mice reconstituted with WT BMMCs (Figure 6C), indicating an
important role for Pak1 in the mast cell–mediated immediate-phase PCA reaction. The profound
reduction in PCA in the Pak1  mice is consistent with the observed reduction in β-hexosaminidase
release in vitro. Collectively, these cellular and in vivo data indicate that Pak1 is critical in IgE-mediated
mast cell degranulation.
Discussion
Local or systemic IgE-mediated hypersensitivity affects greater than 25% of populations in
industrialized countries and clinically manifests as allergic asthma, allergic skin inflammation, and
anaphylaxis, among others.  Mast cells function as key effector cells that contribute to immediate- and
late-phase IgE-mediated inflammatory responses in each of these conditions. Mast cells contribute to
chronic inflammation in IgE-associated allergic responses via the release of preformed granules that
include histamine, prostaglandin, and leukotrienes. The expulsion of these products has immediate
consequences that result in local tissue damage and acute changes in local blood flow. The molecular
regulation of the degranulation process involves multiple biochemical pathways and cytoskeletal
changes resulting from the aggregation and activation of high-affinity IgE receptors (FcϵRI). Drugs
targeting critical intracellular signaling molecules could provide alternative or adjunctive therapy to
medications currently available, many of which are nonspecific.
The demonstration that Pak1 is activated following cross-linking of the IgE receptor together with a
profound reduction in β-hexosaminidase release in Pak1  mast cells provided the first evidence for
Pak1 in influencing immediate mast cell responses in allergen-mediated degranulation. This functional
decrease in degranulation was linked to the inability of Pak1  cells to undergo cortical F-actin
disassembly, a process central to degranulation.  The specificity of these observations was verified
by correction of the degranulation phenotype in Pak1  BMMCs transduced with the Pak1 transgene.
The significance of these in vitro phenotypes was then validated using adoptive transfer of WT and
Pak1  mast cells into W /W  mice followed by passive cutaneous anaphylaxis. Since W /W
mice lack endogenous mast cells, but are phenotypically normal with regard to other lineages
implicated in PCA, the approximate 3-fold reduction in vascular leak observed in mice reconstituted
with Pak1  BMMCs indicates a vital role for Pak1 in mast cells, specifically in allergen-mediated mast
cell degranulation in vivo.
Our findings establish that loss of Pak1 results in a defect in calcium mobilization and impaired
degranulation in vitro. However, when calcium entry is equalized via the non–receptor-dependent
stimulus, calcimycin, degranulation is corrected to WT levels. Rac proteins, upstream effectors of Paks,
regulate changes in intracellular calcium in response to FcϵRI activation in RBL cells via effects on
PLCγ-1/2 and release of calcium from intracellular stores.  However, activation of PLCγ-1 and
release of calcium from intracellular stores are normal in Pak1  BMMCs. Precisely how Pak1 is
involved in calcium mobilization is unclear, but our data indicate that Pak1 is required for events
occurring between the release of calcium from intracellular stores and the influx of extracellular
calcium.
The manner by which intracellular stores of calcium communicate to regulatory proteins and calcium
channels in the plasma membrane is of broad interest and is an area of ongoing investigation applicable
to many pathophysiologic conditions (reviewed in Lewis  and Parekh et al ). Our studies in mast cells
unambiguously position Pak1 as important in this process. The precise mechanism by which Pak1
influences these events is incompletely resolved and will be an area of future investigation. One
possibility is that loss of Pak1 leads to disruptions in cytoskeletal elements that change cell morphology
and organelle location thereby altering signaling from intracellular stores to plasma membrane events
that result in calcium entry. Studies reported here demonstrate alterations in F-actin dynamics. It is
plausible that Pak1 influences calcium influx by modulating other cytoskeletal elements as well. For
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instance, one recent report observed that the microtubule cytoskeleton is important to maintain
allergen-induced calcium influx in mast cell degranulation.  The lack of secretory vesicle movement to
the periphery of the allergen-stimulated Pak1  cell is analogous to confocal images of mast cells
treated with nocodazole, a microtubule depolymerizing agent (Figure S1). The data reported here,
together with the previous link between calcium influx to microtubules,  as well as literature supporting
a role for Pak1 in microtubule regulation,  provide a potential link between Pak1 and calcium
mobilization. Alternatively, or in addition to a mechanism involving cytoskeletal dynamics, Pak1 may
mediate calcium mobilization via interaction with signaling molecules directly involved in calcium
influx. Ke et al provide evidence in cardiac myocytes that Pak1 impacts calcium entry via regulation of
PP2A,  a phosphatase also involved in vesicular fusion in mast cells  (reviewed in Blank and
Rivera ). Further studies will be required to explore the underpinnings of the altered calcium influx in
Pak1  mast cells.
The interaction of Pak1 with signaling molecules, including PP2A by physical interaction and/or
phosphorylation, may have a central role in governing actin dynamics in mast cell degranulation as
well. Recent studies support the long-standing hypothesis that cortical actin filaments function as a
barrier to prevent granules from reaching the plasma membrane for exocytosis and that disassembly of
cortical F-actin is required for vesicle-membrane fusion (reviewed in Blank and Rivera ). In our
studies, after IgE sensitization of Pak1  BMMCs, the cortical F-actin ring forms as expected, but
subsequent fragmentation of that cortical ring occurs to a much lesser extent than in a normal mast
cell. This finding is consistent with studies by Adam et al who demonstrated that overexpression of a
kinase-dead Pak1 mutant in breast cancer cells led to stabilization of F-actin,  suggesting a possible
role for Pak1 in F-actin depolymerization. Given the importance of cortical F-actin disassembly in mast
cell degranulation  (reviewed in Blank and Rivera ), it is plausible that perturbation of normal cortical
actin dissolution by genetic disruption of Pak1 would result in a significant reduction in degranulation in
Pak1  mast cells, as established here. Pak1 participates in the regulation of several proteins important
in F-actin turnover including the LIMK/cofilin pathway and filamin A (reviewed in Bokoch ). Altered
phosphorylation of these substrates in the absence of Pak1 represents one potential mechanism to
explain our findings. In addition, the recently reported interaction between Pak1 and PP2A  may be of
particular relevance to our work since PP1 and PP2 are involved in plasma membrane events during
late steps of exocytosis.  We have generated preliminary data that warrant further investigation of
regulation of these phosphatases by Pak1. Clearly, genetic disruption of Pak1 disturbs the complex
machinery responsible for the breakdown of cortical F-actin, which normally allows release of secretory
granules in response to mast cell allergen challenge.
In summary, despite minimal in vivo consequence to the unchallenged mouse, as evidenced by grossly
normal growth, development, life span, and many normal hematopoietic parameters, genetic disruption
of Pak1 significantly impairs allergen-stimulated mast cell function in vitro and in vivo. This designates
Pak1 as a prospective therapeutic target for reduction of allergen-mediated responses. Small molecular
Pak inhibitors are under development and will allow further study of potential therapeutic uses in IgE-
mediated allergic disease.
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T argeted disruption of the Pak1 allele. (A) Partial restriction map of the native Pak1  gene (genomic locus),
the targeting vector replacing the coding sequence of a portion of the N-terminus, including the p21-binding
domain (PBD) and the inhibitory  domain (ID) with the Neo-resistance gene in the antisense orientation
(targeting vector), and the organization of the targeted Pak1  allele (targeted allele). The 1-kb genomic probe
used for screening is indicated along with the expected sizes of the wild-ty pe (WT) and targeted HindIII
fragments. (B) Genomic Southern blot analy sis (left panel). The nontargeted Pak1  allele (10 kb) is v isualized in
the WT (+/+) mice and the targeted allele (8 kb) is v isualized in the Pak1  (−/−) mice. Both bands can be
appreciated in the heterozy gous (+/−) mice. Western blot analy sis (center panel). WT and Pak1  bone
marrow–derived mast cell (BMMC) ly sates were subjected to immunoblotting with anti-Pak1. The 68-kDa Pak1
protein is present in WT BMMCs and absent in the Pak1  cells. RT-PCR analy sis (right panel). Pak1  cDNA was
amplified by  PCR from BMMCs to generate a 352–base pair fragment (corresponding to base pairs 306-658) in
the WT cells, which is absent in the Pak1  cells. GAPDH mRNA in WT and Pak1  BMMCs is also shown.
Table 1
Hematopoietic characterization ofPak1  mice (age = 8 weeks)
Param eter Pak1 Pak1 P
Body  weight, n = 16 19.6 ± 0.5 19.6 ± 0.4 .924
Peripheral CBC, n = 8
    HCT, % 57  ± 0.4 59 ± 1 .0 .067
    WBC, ×10 21 ± 1 .2 23 ± 1 .4 .468
    % Neutrophils 20 ± 1 .5 20 ± 0.6 .888
    % Ly mphocy tes 7 0 ± 1 .9 68 ± 0.8 .348
Cellularity
    Bone marrow cellularity , ×10  LDMNCs/femur, n = 6 9 ± 0.9 8 ± 0.9 .235
    Spleen cellularity , ×10  nucleated cells/spleen, n = 5 103 ± 4.5 104 ± 5.3 .885
    Peritoneal cellularity , ×10  nucleated cells/peritoneum, n = 3 4 ± 0.2 3 ± 0.1 .057
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Mast cells × 10 /peritoneum, n = 3 53 ± 5.8 40 ± 3.6 .137
Mast cells/mm , ear, n = 6 123 ± 5.6 138 ± 6.6 .112
WBC indicates white blood cell; LDMNC, low-density mononuclear cells.
Values represent the mean ± SEM for the number of mice specified for each parameter. Statistical
significance compared with the +/+ populations was determined using the Student t test where P value
.05 or less.
Mast cells identified by Giemsa stain of cytospins from peritoneal lavage. Total mast cell number
calculated by multiplying percentage mast cells × total peritoneal cellularity.
Mast cells identified by toluidine blue stain of histologic ear sections at baseline.
Figure 2
Characterization of Pak1  bone m arrow–derived m ast cells. (A) Bone marrow–derived mast cell
(BMMC) receptor expression. BMMCs were maintained in culture for 5 weeks, and expression of c-kit and FcϵRI
was measured by  incubation with antimouse CD 117  (c-kit) PE-conjugated antibody , and anti-DNP monoclonal
antibody  IgE clone SPE-7  followed by  incubation with FITC-conjugated anti–mouse IgE secondary  antibody .
Double-positive cells (top right quadrant) are mature mast cells, expressing both c-kit and FcϵRI. Data shown
are representative of 6 independent lines from each genoty pe. (Mean WT = 96.1  + 2.3 SEM % vs Pak1  = 95.3
+ 1 .7  SEM % double-positive cells, n = 6.) (B) IgE-mediated Pak1  activation in BMMCs (representative of 3
independent experiments). IgE-primed BMMCs were stimulated with antigen (DNP) for the indicated times,
ly sates were precipitated with anti-Pak1  antibody , and Pak1  activ ity  was assay ed. (C) Pak1  activation of pS298-
MEK1 in Wt and Pak1  BMMCs. IgE-primed BMMCs were stimulated with antigen (DNP) for the indicated
times. Cell ly sates (“Western blotting”) were subjected to immunoblotting with anti–phospho-S298 MEK1 (top
blot) or anti–total MEK1/2 (bottom blot). (D) Effect of IPA-3 treatment in Wt BMMCs. The length of activation
and the addition of inhibitor are indicated.
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Pak1 is a critical m ediator of m ast cell degranulation in v itro. Mast cell degranulation was assessed by
measuring the release of β-hexosaminidase. (A) IgE-primed WT and Pak1  BMMCs were stimulated with DNP-
HSA for 15 minutes. To determine FcϵRI-independent degranulation, cells were alternatively  stimulated with
calcimy cin (A23187 ). In all conditions, β-hexosaminidase activ ity  was measured in the supernatant and the
extent of degranulation is reported as a percentage of total cellular β-hexosaminidase activ ity . Data are means
plus or minus SEM from triplicate samples in 4 independent experiments. *P < .05, WT versus Pak1 ,
unpaired, 2-tailed, Student t test. (B) Confocal laser scanning microscopy  images of CD63-EGFP in BMMCs.
CD63-EGFP fusion protein was introduced into WT and Pak1  progenitors by  retrov iral transduction as
described in “Methods.” Incorporation of the expressed CD63-EGFP into secretory  vesicle membranes allows
visualization of vesicle location. Fluorescence images of CD63-EGFP (left) and DAPI (right) are shown. Images
are representative of 3 independent experiments. (C) Wild-ty pe Pak1  was reintroduced into Pak1  BMMCs by
lentiv iral transduction. Expression of Pak1  in transduced Wt and Pak1  BMMCs. The recombinant and
endogenous Pak1  proteins are indicated. (D) Release of β-hexosaminidase was measured after sensitization and
antigen stimulation as in panel A. Data are expressed as a percentage of WT degranulation. Proof of phenoty pic
rescue by  reintroduction of Pak1  is shown for a single transduced mast cell line assay ed in triplicate.
Figure 4
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Calcium  responses are altered in Pak1  BMMCs. IgE-primed WT and Pak1  BMMCs were loaded with
Ca -sensitive dy e (fura2) and suspended in Ca -containing medium (A). To detect release from intracellular
stores, cells were suspended in Ca -free media and treated with EGTA prior to stimulation (B). FcϵRI was
activated by  addition of DNP-HSA and changes in intracellular calcium concentration (i[Ca ]) were measured
by  spectrophotofluorimetry . (A) Representative experiment of a WT (black) versus Pak1  (red) BMMC sample
demonstrating decreased Ca -bound fura-2 in the Pak1  cells after antigen stimulation (left panel). Changes
in i[Ca] after addition of digitonin followed by  EGTA are also shown. Average change in i[Ca ] (right panel)
expressed as a percentage of WT change in i[Ca ] from 4 independent experiments, *P < .05, WT versus Pak1
, unpaired, 2-tailed, Student t test. (B) Representative experiment of a WT (black) versus Pak1  (red) BMMC
sample demonstrating similar responses upon antigen stimulation after depletion of extracellular calcium (left
panel). Average percentage increase in i[Ca ] (right panel) from baseline in WT and Pak1  BMMCs from 3
independent experiments, P < .0.57 , WT versus Pak1 , unpaired, 2-tailed, Student t test. (C) Western blot and
densitometry  for activated PLCγ1. NS indicates cells at baseline (nonprimed, nonstimulated). IgE-primed WT
and Pak1  BMMCs were stimulated with DNP for 30 seconds or 1  minute. Cell ly sates (“Western blotting”)
were subjected to immunoblotting with anti–phospho-PLCγ1 (top blot) or anti–total PLCγ1 (bottom blot) and
densitometry  was performed. Intensity  of phosphory lated PLCγ1 bands is represented as the ratio of
phospho/total PLCγ1 for 1  of n = 4 experiments (P = .7 9 and P = .47  at 30 seconds and 60 seconds,
respectively ).
Figure 5
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Pak1 is required for norm al allergen-induced cy toskeletal changes and vesicle trafficking. In all
panels, cells were imaged at baseline (NS), after IgE-priming (4 hours), or following IgE-priming and DNP-HSA
stimulation (5 minutes) as indicated. (A) WT and Pak1  BMMCs were fixed and stained with Alexa-488
phalloidin (to detect F-actin intensity ) and DAPI nuclear stain. The images are representative of 5 experiments.
(B) The number of cells showing F-actin disassembly  was estimated under indicated conditions using a
quantitative intensity  analy sis of Image J. Data are expressed as a percentage of cells with fragmented rings (=
number of cells with fragmented ring/total number of cells imaged × 100) for 4 independent experiments (100
cells counted per experiment); *P < .001, WT versus Pak1 , unpaired, 2-tailed, Student t test. (C) Confocal
laser scanning microscopy  images of WT or Pak1  BMMCs transduced with pCL1EGFP (control, “−”) or
pCL1EGFP-PAK1 (Pak1  transgene, “+”) as indicated. Imaged cells have been treated with IgE and DNP.
Figure 6
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Genetic disruption of Pak1 dim inishes PCA in vivo. Evans blue extravasation after antigen challenge.
(A,B) Pak1  or WT mice (n = 5 genoty pe) were sensitized by  intradermal injection of anti-DNP IgE (1 :44
dilution, 1  μg/mL) into the right ear and with PBS into the left ear. After 20 hours, mice were challenged by
−/−
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intravenous injection of antigen (DNP-HSA) in PBS/Evans blue. IgE-primed (right) ears 30 minutes after antigen
challenge are shown qualitatively  (bottom). From each ear, Evans blue was extracted and the intensity  of the
dy e was measured by  absorption at 620 nm. *P < .05, WT versus Pak1 , unpaired, 2-tailed, Student t test. (C)
Mast cell–deficient W /W  mice (n = 5) were reconstituted locally  in the ears by  intradermal injection of WT
or Pak1  mast cells. The mice were then sensitized by  intradermal injection of anti-DNP IgE into the right ear
and with PBS into the left ear as in panel A. IgE-primed (right) ears from mice reconstituted with WT or Pak1
mast cells 30 minutes after antigen challenge are shown qualitatively  (bottom). From each ear, Evans blue was
extracted and the intensity  of the dy e was measured by  absorption at 620 nm. *P < .05, WT versus Pak1 ,
unpaired, 2-tailed, Student t test.
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